Cargando…
Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
BACKGROUND: In normal circumstances, AT secretes anti-inflammatory adipokines (AAKs) which regulates lipid metabolism, insulin sensitivity, vascular hemostasis, and angiogenesis. However, during obesity AT dysfunction occurs and leads to microvascular imbalance and secretes several pro-inflammatory...
Autores principales: | Roy, Probin Kr, Islam, Johirul, Lalhlenmawia, Hauzel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073393/ https://www.ncbi.nlm.nih.gov/pubmed/37014444 http://dx.doi.org/10.1186/s43044-023-00352-7 |
Ejemplares similares
-
Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013) -
Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children
por: D'Adamo, Ebe, et al.
Publicado: (2015) -
Prevalence of dyslipidemia, atherogenic and cardiovascular risk in overweight and obese adolescents
por: de Andrades, Clara dos Santos, et al.
Publicado: (2023) -
Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019) -
Association of Adipokines, Insulin Resistance, Hypertension and Dyslipidemia in Patients with Psoriasis Vulgaris
por: Coban, Melis, et al.
Publicado: (2016)